These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2745033)

  • 1. The prognostic value of post chemotherapy serum CA 125 in epithelial ovarian cancer.
    Teeling M; McGing P; Carney DN
    Ir J Med Sci; 1989 Mar; 158(3):59-62. PubMed ID: 2745033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The value of CA 125 determination in the serum of patients with ovarian cancer].
    Bartel U; Johannsen B; Elling D
    Zentralbl Gynakol; 1989; 111(5):301-9. PubMed ID: 2728673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the CA 125 assay in the management of ovarian cancer.
    Niloff JM
    Oncology (Williston Park); 1988 Aug; 2(8):67-76. PubMed ID: 3275060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of serum CA(125) level change during chemotherapy post-surgery in patients with advanced epithelial ovarian carcinoma].
    Lan CY; Huang H; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):732-6. PubMed ID: 19087537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA 125 in monitoring chemotherapy of patients with ovarian cancer: early response to the treatment.
    Markowska J; Kopczyński Z; Manyś G; Szewierski Z
    Neoplasma; 1990; 37(6):687-92. PubMed ID: 2274087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of CA-125 to predict survival of patients with ovarian carcinoma. North Thames Cooperative Group.
    Rustin GJ; Gennings JN; Nelstrop AE; Covarrubias H; Lambert HE; Bagshawe KD
    J Clin Oncol; 1989 Nov; 7(11):1667-71. PubMed ID: 2681555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of the half-life of serum CA 125 in patients responding to chemotherapy for epithelial ovarian carcinoma.
    Hawkins RE; Roberts K; Wiltshaw E; Mundy J; Fryatt IJ; McCready VR
    Br J Obstet Gynaecol; 1989 Dec; 96(12):1395-9. PubMed ID: 2620051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CA 125 as a tumour marker in epithelial ovarian cancer.
    Sheehan JD; Duffy MJ; Allen MA; Fennelly JJ
    Ir J Med Sci; 1989 Jan; 158(1):10-3. PubMed ID: 2737852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic value of CA 125 initial half-life measured during first-line chemotherapy in 62 patients with epithelial ovarian cancer stage III or IV].
    Riedinger JM; Barillot I; Coudert B; Fargeot P; Berriolo-Riedinger A; Guerrin J
    Bull Cancer; 1996 Aug; 83(8):654-63. PubMed ID: 8869046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An independent evaluation of the potential clinical usefulness of proposed CA-125 indices previously shown to be of prognostic significance in epithelial ovarian cancer.
    Cruickshank DJ; Paul J; Lewis CR; McAllister EJ; Kaye SB
    Br J Cancer; 1992 Apr; 65(4):597-600. PubMed ID: 1562469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological monitoring of epithelial ovarian cancer.
    Fisken J; Leonard RC; Badley A; Jönrup I; Aspinall L; Sturgeon C; Roulston JE
    Dis Markers; 1991; 9(3-4):175-90. PubMed ID: 1813209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CA 125 as an independent prognostic factor for survival in patients with epithelial ovarian cancer.
    Sevelda P; Schemper M; Spona J
    Am J Obstet Gynecol; 1989 Nov; 161(5):1213-6. PubMed ID: 2589442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer.
    Plante M; Rubin SC; Wong GY; Federici MG; Finstad CL; Gastl GA
    Cancer; 1994 Apr; 73(7):1882-8. PubMed ID: 8137215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early serum CA125 response and outcome in epithelial ovarian cancer.
    Redman CW; Blackledge GR; Kelly K; Powell J; Buxton EJ; Luesley DM
    Eur J Cancer; 1990; 26(5):593-6. PubMed ID: 2144746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer.
    Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
    Onkologie; 2008 Jun; 31(6):315-20. PubMed ID: 18547972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of tumor-associated CA-125 antigen in the diagnosis and monitoring of ovarian cancer].
    Ial'chenko NA; Levik NN; Musin II
    Akush Ginekol (Mosk); 1991 Sep; (9):61-2. PubMed ID: 1746705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of the ovarian cancer-associated antigen CA 125 in monitoring tumor burden and response to chemotherapy.
    Quaranta M; Coviello M; Donadeo A; Rella C; Lorusso V; Micelli G; Lucarelli C
    Tumori; 1991 Apr; 77(2):167-9. PubMed ID: 2048231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CA 125 in monitoring clinical course in ovarian cancer patients. A prospective clinical study.
    Markowska J; Manys G; Szewierski Z
    Eur J Gynaecol Oncol; 1992; 13(2):201-4. PubMed ID: 1587296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of early changes in the serum CA-125 antigen level on overall survival in advanced ovarian cancer.
    Markman M; Federico M; Liu PY; Hannigan E; Alberts D
    Gynecol Oncol; 2006 Oct; 103(1):195-8. PubMed ID: 16595148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CA 125 measured before second-look laparotomy is an independent prognostic factor for survival in patients with epithelial ovarian cancer.
    Makar AP; Kristensen GB; Børmer OP; Tropé CG
    Gynecol Oncol; 1992 Jun; 45(3):323-8. PubMed ID: 1612511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.